March 7, 2019
The initiative will also provide critical funding to develop new research alliances and undertake innovation to enable significant progress against cancer outcomes
Over next five years, the total research funding for the initiative will be more than US$13 million. Cancer Research UK’s share in the funding will be US$6.5 million
The tie-up will align the best researchers, scientists, healthcare organizations and institutions to innovate high value and low cost outcomes for cancer care
The participants in the partnership will be trained in cutting edge technology that will help in securing tenure-track research positions, thus aiding skill development
The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved a preliminary agreement between India and UK on cancer research. The deal, first signed on November 14, got approval on March 7. The India-UK Cancer Research Initiative will identify a core set of challenges that address affordability, prevention and care of cancer by bringing together Indian and UK experts in clinical and demographic researches, new technologies and physical sciences. The initiative will also provide funding to develop new research alliances and undertake innovation to enable significant progress against cancer outcomes.
Over next five years, the total research funding for the initiative will be more than US$13 million. Cancer Research UK’s share in the funding will be US$6.5 million, while India’s Department of Biotechnology will provide the rest. Despite the surge in technological, biomedical, pharmaceutical and clinical innovations aimed at improving cancer outcomes, the overburdened healthcare systems across the globe remain ill equipped to meet the massive burden of escalating cancer care costs. The India-UK Cancer Research Initiative sets forth a roadmap for tie-ups into the required innovations for the best cancer treatment.
The partnership will align the best researchers, scientists, healthcare organizations and institutions to a multi-disciplinary research platform leading to high value, low cost outcomes for cancer care. Through this initiative the number of positions for doctoral-level, post-doctoral level researchers and early career scientists are expected to grow. They will not only be trained in cutting edge technology but will also be trained in essential leadership and project management skills which would help them in securing tenure-track research positions in academia or in bio-pharma industry, thus aiding skill development.
